Q/C Technologies, Inc. Cash and Restricted Cash
Q/C Technologies, Inc. (QCLS) had Cash and Restricted Cash of $1.80 million as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2018-11-14
- 2018-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.80M.
- 2018-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $775.96K.
- 2017-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $438.43K.
- 2017-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $135.13K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2018-09-30 | $1.80M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $775.96K 10-Q · filed 2018-08-14 |
| 2017-12-31 | $438.43K 10-Q · filed 2018-11-14 |
| 2017-09-30 | $135.13K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $197.18K 10-Q · filed 2018-08-14 |
| 2016-12-31 | $72.70K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |